Evidence map›Paper›PMID 27822183›Full record

ReviewFrontiers in synaptic neuroscience2016

Can the Lateral Habenula Crack the Serotonin Code?

Anna Tchenio, Kristina Valentinova, Manuel Mameli

Abstract readReview
In one paragraph

Review in Frontiers in synaptic neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Lateral Habenula 5-HTInternational journal of molecular sciences · 2021
    Article
  5. Review
  6. Article
  7. Activation of 5-HTBehavioural brain research · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna TchenioInstitut du Fer à MoulinParis, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 839Paris, France; Université Pierre et Marie CurieParis, France.
Kristina ValentinovaInstitut du Fer à MoulinParis, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 839Paris, France; Université Pierre et Marie CurieParis, France.
Manuel MameliInstitut du Fer à MoulinParis, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 839Paris, France; Université Pierre et Marie CurieParis, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lateral habenula (LHb) and the serotonergic system both contribute to motivational states by encoding rewarding and aversive signals. Converging evidence suggests that perturbation of these systems is critical for the pathophysiology of mood disorders. Anatomical and functional studies indicate that the serotonergic system and the LHb are interconnected in a forward-feedback loop. However, how serotonin release modifies the synaptic and cellular properties of LHb neurons and whether this has any behavioral repercussions remain poorly investigated. In this review article, we discuss insights gained from rodents and humans regarding the implications of the serotonin system and the LHb in aversion encoding and related disorders. We then describe the type, properties and pharmacology of serotonergic receptors expressed throughout the LHb. Finally, we discuss physiological data reporting how serotonergic signaling modifies synaptic transmission and neuronal activity within the LHb. Altogether, we combine a mechanistic- and circuit-level knowledge to provide an overview on how the LHb integrates serotonergic signals, a process potentially contributing to LHb-dependent encoding of valenced external stimuli.

Indexed as

5-HTlateral habenula (LHb)neuromodulationraphe nucleisynapses

Identifiers

PMID27822183
PMCPMC5075531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.